Navigation Links
Cumberland Pharmaceuticals Announces Pricing of Its Initial Public Offering of Common Stock
Date:8/10/2009

include hospital acute care and gastroenterology. Cumberland markets Acetadote((R)) for the treatment of acetaminophen poisoning and Kristalose((R)), a prescription strength laxative. The Company also recently received FDA approval for Caldolor((R)), the first injectable treatment for pain and fever available in the United States, and is preparing for the commercial launch of that product. Cumberland is dedicated to providing innovative products which improve quality of care for patients.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor will there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

Statements contained in this press release that are not historical facts are "forwardlooking" statements within the meaning of the federal securities laws. Forward-looking statements, including statements regarding the completion of the proposed initial public offering and any of the terms thereof, are uncertain and subject to a variety of risks that could cause actual results to differ materially from those expected by the Company. Additional information regarding these and other risks can be found in the Company's registration statement relating to the proposed offering.


'/>"/>
SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cumberland Pharmaceuticals Announces FDA Approval of Caldolor(TM)
2. Cumberland Pharmaceuticals Provides Hospital In-Service Webcast for Acetadote(R)
3. Cumberland Emerging Technologies and UT Research Foundation Sign License Agreement for New Technology
4. Cumberland Pharmaceuticals Appoints Lee Product Director
5. Neurotech Announces the Opening of Its GMP Manufacturing Facility in Cumberland, Rhode Island
6. Cumberland Pharmaceuticals Taps Industry Veteran for Key Executive Position
7. OncoGenex Pharmaceuticals Announces Issuance of Key Patent for OGX-011
8. Vanda Pharmaceuticals Reports Second Quarter 2009 Results
9. Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes
10. Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009
11. Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals Lead Antibody
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Cynvenio, a cancer diagnostics company focused ... analysis of tumor cells in the bloodstream, today announced ... decision support application powered by CollabRx, Inc. , ... test, Therapy Finder will provide breast cancer patients and ...
(Date:1/15/2014)... Houston, TX (PRWEB) January 15, 2014 ... Alzheimer’s disease, and about 1 in 3 seniors will ... ( source ). These jaw-dropping figures have shocked many ... function and, hopefully, help prevent these tragic age-related cognitive ...
(Date:1/15/2014)... Freeslate, Inc ., the leading provider ... Limited, one of India’s top five pharmaceutical companies, has ... for high throughput solid form screening. , ... wide range of quality, affordable generic and branded formulations ...
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine company ... under simulated embryonic conditions, today announced that they have ... Inc. for physician-dispensed aesthetic products containing Histogen’s proprietary multipotent ... is an amendment to the existing license between Histogen ...
Breaking Biology Technology:Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3
... , , , E-mail us your application notes for inclusion in this ... of electroporation , cuvettes. , , , ... , Bacteria, gram negative , , ... href="http://www.biocompare.com/techart.asp?id=575">Actinobacillus , ...
... , , , , , ... Katherine A. Borkovich PhD, University of Texas-Houston Medical Center, , ... Texas. , Kimberly Vollmer, Brinkmann™ Instruments Inc., BioSystems Application ... , , , , ...
... , , , , , ... , regulatory promoter and enhancer sequences as well ... element under investigation (promoter, enhancer) is cloned , ... used to transfect cells. Quantification of the reporter ...
Cached Biology Technology:Eppendorf Electroporation Application Notes Your participation , is highly welcome !!! 2Eppendorf Electroporation Application Notes Your participation , is highly welcome !!! 3Eppendorf Electroporation Application Notes Your participation , is highly welcome !!! 4Eppendorf Electroporation Application Notes Your participation , is highly welcome !!! 5Efficient Transfection of Neurospora Crassa 2Efficient Transfection of Neurospora Crassa 3Efficient Transfection of Neurospora Crassa 4Efficient Transfection of Neurospora Crassa 5Genetic Reporter Systems 2Genetic Reporter Systems 3Genetic Reporter Systems 4
(Date:4/18/2014)... as soon as they,re planted may be good news for ... In the wild, a plant whose seeds sprouted at the ... than just an insurance policy against late frosts or unexpected ... advantages too: Plants whose seeds put off sprouting until ... in a team of researchers working at the National Evolutionary ...
(Date:4/17/2014)... peptide inhibits RSV infection , Respiratory syncytial ... respiratory tract infections, generating life-threating illness in very ... therapies are limited. RSV enters host cells through ... six-helix fusogenic bundle. Small interfering peptides that prevent ... these peptides are highly susceptible to degradation. In ...
(Date:4/17/2014)... Professor Luca Razzari of the nergie Matriaux Tlcommunications ... from the John R. Evans Leaders Fund of ... acquisition of state-of-the-art biotech and nanophotonics equipment. To ... the Ministre de l,Enseignement suprieur, de la Recherche, ... These new laboratories will help us develop new ...
Breaking Biology News(10 mins):Plants with dormant seeds give rise to more species 2JCI online ahead of print table of contents for April 17, 2014 2JCI online ahead of print table of contents for April 17, 2014 3JCI online ahead of print table of contents for April 17, 2014 4JCI online ahead of print table of contents for April 17, 2014 5JCI online ahead of print table of contents for April 17, 2014 6New state-of-the-art biotech and nanotech equipment for INRS 2
... to a virulent family of bacteria called Yersinia, a ... poisoning. These bacteria insert into their host cells proteins ... other things -- disrupting the cells' normal structure. One ... skeleton. Now, a study published by Rockefeller University researchers ...
... announced today that researchers at the Translational Genomics ... the Affymetrix 500K Array to discover a gene--called ... findings may be used to develop new medicines ... by providing scientists with a better understanding of ...
... birth weights tend to have a much lower quality of life ... study published in the latest issue of the UK-based Journal of ... weights of 1500g or less and compared them with a control ... of life when it came to physical, emotional, cognitive and social ...
Cached Biology News:A wolf in sheep's clothing: Plague bacteria reveal one of their virulence tricks 2Affymetrix 500K array used to identify memory gene 2Very low birth weight linked to reduced quality of life in pre-school children 2
... FL is equipped with ... measurement technologies that complement ... advanced features of Fluoroskan ... Fluoroskan Ascent FL provides ...
Mouse monoclonal [AZ24] to Polo like kinase ( Abpromise for all tested applications)....
... the blending of thermostable DNA polymerases with ... Template PCR Systems, now introduces the Expand ... product of a family of next-generation PCR ... DNA Polymerase with a novel proofreading protein ...
... Source: Escherichia coli RY 13 5'G AATTC3' ... for 15 min or ethanol precipitation. Storage Conditions: ... 1.0mM DTT, 0.15% Triton X-100, 0.01% BSA, 50% ... Store at -20C. Unit Definition: One unit is ...
Biology Products: